OrthoPediatrics financials
$22.76+0.80%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M | $71.1M | $72.6M | $57.6M | $45.6M |
| Gross profit | $172.7M | $148.6M | $111.3M | $90.7M | $73.4M | $55.0M | $54.6M | $42.7M | $34.5M |
| Gross margin | 73.1% | 72.6% | 74.8% | 74.1% | 74.9% | 77.4% | 75.3% | 74.2% | 75.5% |
| Operating income | -$39.2M | -$35.0M | -$26.8M | $531.0K | -$16.2M | -$30.3M | -$9.1M | -$9.6M | -$6.5M |
| Net income | -$39.6M | -$37.8M | -$21.0M | $1.3M | -$16.3M | -$32.9M | -$13.7M | -$12.0M | -$23.5M |
| Net margin | −16.8% | −18.5% | −14.1% | 1.0% | −16.6% | −46.3% | −18.9% | −20.9% | −51.6% |
| Diluted EPS | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 | $-0.94 | $-0.96 | $-5.86 |
| EBITDA | -$7.9M | -$10.4M | -$8.4M | -$8.7M | -$7.2M | -$12.4M | -$4.4M | -$6.7M | -$4.1M |
| Operating cash flow | -$4.9M | -$27.0M | -$27.0M | -$21.8M | -$13.1M | -$18.5M | -$17.8M | -$15.6M | -$7.2M |
| Free cash flow | -$16.0M | -$41.3M | -$44.5M | -$31.8M | -$21.2M | -$29.0M | -$29.6M | -$20.8M | -$12.4M |
| Diluted shares | 23.5M | 23.1M | 22.7M | 20.9M | 19.3M | 18.1M | 14.6M | 12.6M | 4.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.6M | $43.8M | $31.1M | $9.0M | $7.6M | $28.8M |
| Short-term investments | $41.3M | $25.0M | $49.3M | $109.3M | $45.9M | $55.1M |
| Total debt | $99.7M | $72.7M | $10.1M | $763.0K | $907.0K | $1.0M |
| Total assets | $508.6M | $473.2M | $438.7M | $427.7M | $304.3M | $320.4M |
| Total liabilities | $162.0M | $118.6M | $61.7M | $49.1M | $78.9M | $85.6M |
| Shareholders' equity | $346.6M | $354.6M | $377.0M | $378.6M | $225.4M | $234.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology